Supplemental material
Open access
3,269
Views
25
CrossRef citations to date
0
Altmetric
Original Articles
Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis
Xinhua YangDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaView further author information
, Xiaofei ZhangDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaCorrespondence[email protected]
View further author information
, View further author information
Bin LinDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaView further author information
, Xiao FengDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaView further author information
& Aixingzi AiliDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaView further author information
Pages 485-491
|
Received 11 Dec 2018, Accepted 10 Mar 2019, Published online: 17 Apr 2019
Related Research Data
Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
Source:
Elsevier BV
Medical treatment for adenomyosis and/or adenomyoma
Source:
Elsevier BV
Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis
Source:
Elsevier BV
Adenomyosis and Abnormal Uterine Bleeding (AUB-A)—Pathogenesis, diagnosis, and management
Source:
Elsevier BV
Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis
Source:
Figshare
Sonographic Findings in Patients with Adenomyosis: Can Sonography Assist in Predicting Extent of Disease?
Source:
American Roentgen Ray Society
Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis
Source:
S. Karger AG
Minimally invasive treatment of adenomyosis
Source:
Elsevier BV
Mirena® (Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception
Source:
Elsevier BV
Levonorgestrel-releasing intra-uterine systems as female contraceptives
Source:
Informa UK Limited
Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma
Source:
Oxford University Press (OUP)
Uterine adenomyosis and adenomyoma: the surgical approach
Source:
Elsevier BV
Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center
Source:
Elsevier BV
High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results.
Source:
Elsevier BV
Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis
Source:
Elsevier BV
Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis
Source:
Figshare
High intensity focused ultrasound: The fundamentals, clinical applications and research trends
Source:
Elsevier BV
A Retrospective Study
Source:
Ovid Technologies (Wolters Kluwer Health)
Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache
Source:
SAGE Publications
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.